Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Q2 2026 vs. Q1 2026
How the institutions holding Verve Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 3 | 1 | 3 | +1 |
| Shares | 27.1K | 1 | 27.3K | +215 (+0.8%) |
| Value | $0 | $0 | $0 | $0 |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Verve Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Financial Gravity Companies, Inc. | 1 | $0 | 0.00% |
| GAMMA Investing LLC | 257 | $0 | 0.00% |
Sold out (1)
Institutions that held Verve Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Murphy & Mullick Capital Management Corp | 43 | $0 |
Not filed for Q2 2026 yet (1)
Institutions that held Verve Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Sofos Investments, Inc. | 1 | $0 |